Accessibility Menu
 
Edwards Lifesciences logo

Edwards Lifesciences

(NYSE) EW

Current Price$77.83
Market Cap$46.10B
Since IPO (2000)+5,715%
5 Year-13%
1 Year+7%
1 Month-2%

Edwards Lifesciences Financials at a Glance

Market Cap

$46.10B

Revenue (TTM)

$6.30B

Net Income (TTM)

$1.09B

EPS (TTM)

$1.84

P/E Ratio

43.44

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$77.83

Volume

85,654

Open

$80.26

Previous Close

$79.96

Daily Range

$76.54 - $80.26

52-Week Range

$72.30 - $87.89

EW: Motley Fool Moneyball Superscore

69

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Edwards Lifesciences

Industry

Healthcare Equipment and Supplies

Employees

16,000

CEO

Bernard J. Zovighian, MBA

Headquarters

Irvine, CA 92614, US

EW Financials

Key Financial Metrics (TTM)

Gross Margin

78%

Operating Margin

28%

Net Income Margin

17%

Return on Equity

11%

Return on Capital

15%

Return on Assets

8%

Earnings Yield

2.30%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$46.10B

Shares Outstanding

576.54M

Volume

85.65K

Avg. Volume

5.12M

Financials (TTM)

Gross Profit

$4.74B

Operating Income

$1.64B

EBITDA

$1.43B

Operating Cash Flow

$1.60B

Capital Expenditure

$260.20M

Free Cash Flow

$1.33B

Cash & ST Invst.

$4.23B

Total Debt

$705.40M

Edwards Lifesciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$1.65B

+16.7%

Gross Profit

$1.29B

+16.0%

Gross Margin

78.21%

N/A

Market Cap

$46.10B

N/A

Market Cap/Employee

$2.92M

N/A

Employees

15,800

N/A

Net Income

$380.70M

+6.3%

EBITDA

$514.70M

+9.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$2.97B

-7.2%

Accounts Receivable

$973.00M

+29.4%

Inventory

$1.12B

+0.5%

Long Term Debt

$678.60M

+0.4%

Short Term Debt

$24.30M

+2.5%

Return on Assets

8.20%

N/A

Return on Invested Capital

14.62%

N/A

Free Cash Flow

$21.10M

-109.4%

Operating Cash Flow

$43.80M

-84.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CAHCardinal Health, Inc.
$183.11-0.29%
ARGXargenx SE
$802.13+2.55%
HLNHaleon plc
$9.03-0.93%
BDXBecton, Dickinson and Company
$144.42-3.35%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$16.47+0.05%
NOKNokia
$13.73+0.07%
ODYSOdysight.ai
$5.59+0.25%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$42.22-0.01%

Questions About EW

What is the current price of Edwards Lifesciences?

Edwards Lifesciences is trading at $77.82 per share.

What is the 52-week range for Edwards Lifesciences?

Over the past 52 weeks, Edwards Lifesciences has traded between $72.30 and $87.89.

How much debt does Edwards Lifesciences have?

As of the most recent reporting period, Edwards Lifesciences reported total debt of $702.90M.

How much cash does Edwards Lifesciences have on hand?

Edwards Lifesciences reported $2.45B in cash and cash equivalents in its most recent financial results.

What is Edwards Lifesciences’s dividend yield?

Edwards Lifesciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.